Clinical Approach to Nausea and Vomiting in Pregnancy
Comprehensive Practical Framework1. Symptom Overview
Understanding the clinical significance and classification of nausea and vomiting in pregnancy
Nausea and vomiting in pregnancy (NVP) is one of the most common medical conditions encountered in obstetric practice, affecting approximately 50 to 80% of all pregnant women. Often colloquially referred to as “morning sickness,” this term is misleading as symptoms occur throughout the day in most affected individuals. While the majority of cases are mild and self-limiting, the severe end of the spectrum—hyperemesis gravidarum—affects 0.3 to 3% of pregnancies and represents one of the leading causes of hospitalization during the first half of pregnancy. NVP accounts for significant healthcare utilization, with an estimated economic burden exceeding $1.7 billion annually in the United States alone when considering lost work productivity and medical costs.
Definitions
Nausea and Vomiting of Pregnancy (NVP): A spectrum of symptoms ranging from mild nausea to severe, intractable vomiting occurring during pregnancy, typically beginning in the first trimester and resolving by mid-pregnancy in most cases.
Hyperemesis Gravidarum (HG): The severe form of NVP characterized by persistent vomiting, weight loss greater than 5% of pre-pregnancy weight, dehydration, ketonuria, and electrolyte disturbances requiring medical intervention.
Classification by Timing and Duration
| Category | Typical Onset | Resolution | Clinical Significance |
|---|---|---|---|
| Early-Onset NVP | 4 to 6 weeks gestation | By 12 to 14 weeks | Most common pattern; correlates with rising hCG levels; generally favorable prognosis |
| Peak Symptom Period | 7 to 12 weeks gestation | Gradual improvement after 12 weeks | Coincides with peak hCG concentrations; symptoms often most severe during this window |
| Persistent NVP | First trimester | Continues beyond 20 weeks | Affects 10 to 20% of women; requires exclusion of alternative diagnoses; may indicate hyperemesis gravidarum |
| Late-Onset Symptoms | After 9 weeks gestation | Variable | Atypical presentation; mandates investigation for non-pregnancy causes |
Classification by Severity
Mild NVP
Characteristics: Intermittent nausea with or without occasional vomiting; able to maintain oral intake and hydration; no weight loss; minimal impact on daily activities.
Frequency: Affects approximately 50% of pregnant women
Management: Dietary modifications, lifestyle adjustments, and reassurance typically sufficient
Moderate NVP
Characteristics: Frequent nausea and vomiting (3 to 5 episodes daily); reduced but maintained oral intake; mild weight loss (less than 5%); moderate impact on quality of life and work.
Frequency: Affects approximately 25% of pregnant women
Management: May require antiemetic therapy; close monitoring recommended
Severe NVP / Hyperemesis Gravidarum
Characteristics: Persistent, intractable vomiting; inability to maintain oral hydration; weight loss greater than 5%; ketonuria; electrolyte abnormalities; significant functional impairment.
Frequency: Affects 0.3 to 3% of pregnancies
Management: Requires medical intervention including intravenous fluids, antiemetics, and potentially hospitalization
Refractory Hyperemesis Gravidarum
Characteristics: Symptoms persist despite standard antiemetic therapy; may develop Wernicke encephalopathy if untreated; severe malnutrition possible.
Frequency: Rare (less than 0.5%)
Management: Hospitalization required; parenteral nutrition may be necessary; consider alternative diagnoses
Classification by Pattern and Timing of Symptoms
| Pattern | Description | Clinical Implications |
|---|---|---|
| Morning-Predominant | Symptoms worst upon waking, improving throughout the day | Classic “morning sickness” pattern; often responds well to pre-emptive eating before rising |
| Evening-Predominant | Symptoms worsen as day progresses, worst in evening hours | May be exacerbated by fatigue and accumulated triggers throughout day |
| Continuous/All-Day | Persistent nausea with or without vomiting throughout waking hours | More likely to represent moderate-to-severe NVP; greater impact on quality of life |
| Trigger-Related | Symptoms precipitated by specific odors, foods, or stimuli | Suggests heightened olfactory sensitivity; avoidance strategies may be particularly helpful |
| Post-Prandial | Nausea and vomiting occurring shortly after eating | May suggest gastric dysmotility component; small frequent meals may help |
Risk Factors for NVP and Hyperemesis Gravidarum
Pregnancy-Related Factors
- Multiple gestation: Higher hCG levels increase risk
- Molar pregnancy: Markedly elevated hCG
- Female fetus: Modestly increased risk
- First pregnancy: Nulliparity associated with increased symptoms
- History of NVP/HG in prior pregnancy: Strong predictor of recurrence (15 to 20% recurrence for HG)
Patient-Related Factors
- History of motion sickness: Suggests vestibular sensitivity
- Migraine history: Shared pathophysiology suspected
- Family history of HG: Genetic component demonstrated
- Helicobacter pylori infection: Associated with increased severity
- Psychiatric conditions: Depression and anxiety may exacerbate symptoms
- Body mass index extremes: Both underweight and obesity associated
Key Concept — The Spectrum of Disease: Nausea and vomiting of pregnancy exists on a continuum from mild, self-limited symptoms affecting the majority of pregnant women to the severe, potentially life-threatening condition of hyperemesis gravidarum. The critical clinical tasks are: (1) distinguishing physiologic NVP from hyperemesis gravidarum requiring intervention, (2) identifying red flags suggesting alternative diagnoses, and (3) recognizing when symptoms threaten maternal or fetal wellbeing.
Impact on Quality of Life and Outcomes
| Domain | Mild NVP | Moderate NVP | Hyperemesis Gravidarum |
|---|---|---|---|
| Work/Productivity | Minimal disruption | Reduced productivity; occasional missed days | Often unable to work; significant economic impact |
| Social Functioning | Generally preserved | Some limitation of activities | Severe isolation; depression common |
| Nutritional Status | Maintained | May have mild deficiencies | Risk of thiamine deficiency, electrolyte abnormalities |
| Pregnancy Outcomes | No adverse effect; may be associated with lower miscarriage risk | Generally favorable with treatment | Low birth weight and preterm delivery if untreated; rarely, maternal complications |
Reassuring Associations
While NVP causes significant distress, it is important to counsel patients that mild-to-moderate symptoms are associated with favorable pregnancy outcomes, including reduced risk of miscarriage, stillbirth, and preterm delivery. This association is thought to reflect adequate placental hormone production. However, this reassurance should not minimize the real suffering patients experience or delay appropriate treatment.
2. Pathophysiology and Mechanisms
Understanding the underlying mechanisms of nausea and vomiting in pregnancy
The pathophysiology of nausea and vomiting in pregnancy is complex and multifactorial, involving hormonal, neurological, gastrointestinal, and psychological components. While no single mechanism fully explains all cases, understanding these pathways helps guide both diagnosis and management. The condition likely represents a final common pathway resulting from the interaction of multiple factors, with individual susceptibility varying based on genetic and environmental influences.
The Vomiting Reflex Arc
| Component | Structure | Function in NVP |
|---|---|---|
| Afferent Inputs | Vagus nerve (from GI tract), vestibular system, higher cortical centers, chemoreceptor trigger zone | Transmit signals from multiple sources to the vomiting center; vagal afferents particularly important in NVP |
| Chemoreceptor Trigger Zone (CTZ) | Area postrema in floor of fourth ventricle; outside blood-brain barrier | Detects circulating emetogenic substances including hCG and estrogen; highly sensitive to hormonal changes |
| Vomiting Center | Nucleus tractus solitarius in medulla oblongata | Integrates afferent inputs and coordinates the emetic response |
| Key Neurotransmitters | Serotonin (5-HT3), dopamine, histamine, acetylcholine, substance P (NK1) | Multiple receptor systems involved; explains why combination antiemetic therapy often needed |
| Efferent Output | Vagus nerve, phrenic nerve, spinal nerves to abdominal muscles | Coordinate diaphragmatic contraction, abdominal muscle contraction, and reverse peristalsis |
Hormonal Mechanisms
Human Chorionic Gonadotropin (hCG)
Evidence: Temporal correlation between hCG levels and symptom severity; higher levels in molar pregnancy and multiple gestations associated with worse symptoms.
Mechanism: hCG may directly stimulate CTZ; also stimulates thyroid via TSH receptor cross-reactivity causing transient hyperthyroidism.
Clinical relevance: Explains typical onset at 4 to 6 weeks, peak at 9 to 12 weeks, and improvement after first trimester as hCG plateaus.
Estrogen
Evidence: Women with history of estrogen-induced nausea (oral contraceptives, hormone therapy) at higher risk; estrogen levels correlate with symptom severity.
Mechanism: Estrogen sensitizes CTZ and vestibular system; slows gastric emptying; enhances olfactory sensitivity.
Clinical relevance: May explain heightened smell sensitivity and trigger-related symptoms characteristic of NVP.
Progesterone
Evidence: Progesterone relaxes smooth muscle throughout body including GI tract.
Mechanism: Causes decreased lower esophageal sphincter tone (reflux), delayed gastric emptying, and reduced intestinal motility.
Clinical relevance: Contributes to gastroparesis-like symptoms; explains why prokinetic agents may help some patients.
Additional Hormonal Contributors
| Hormone/Factor | Change in Pregnancy | Proposed Role in NVP |
|---|---|---|
| Thyroid Hormones | Transient hyperthyroidism in 60% of hyperemesis gravidarum cases due to hCG-TSH receptor cross-reactivity | Gestational transient thyrotoxicosis may exacerbate symptoms; usually resolves spontaneously |
| GDF15 (Growth Differentiation Factor 15) | Dramatically increased; produced by placenta | Emerging as key mediator: Acts on brainstem GFRAL receptors to induce nausea; genetic variants in GDF15/GFRAL strongly associated with hyperemesis gravidarum |
| Leptin | Increased in pregnancy; higher in hyperemesis gravidarum | May contribute to appetite suppression and nausea |
| Prostaglandins | Elevated E2 levels | May slow GI motility and contribute to nausea |
The GDF15 Breakthrough
Recent research has identified Growth Differentiation Factor 15 (GDF15) as a major mediator of pregnancy nausea. This hormone, produced by the placenta, acts on GFRAL receptors in the brainstem to induce nausea and vomiting. Women with naturally low pre-pregnancy GDF15 levels experience a more dramatic relative increase during pregnancy, resulting in more severe symptoms. Genetic variants affecting GDF15 or its receptor are strongly associated with hyperemesis gravidarum, representing the most significant advance in understanding NVP pathophysiology in decades.
Gastrointestinal Mechanisms
Gastric Dysmotility
- Delayed gastric emptying: Documented in symptomatic pregnant women; improves after delivery
- Gastric dysrhythmias: Abnormal slow-wave activity on electrogastrography correlates with symptoms
- Lower esophageal sphincter relaxation: Contributes to reflux symptoms that may worsen nausea
- Small bowel dysmotility: May contribute to bloating and discomfort
Helicobacter pylori Association
- Higher prevalence: H. pylori infection more common in hyperemesis gravidarum patients
- Mechanism: May exacerbate hormonal effects on gastric mucosa
- Treatment implications: Eradication postpartum may reduce recurrence risk in subsequent pregnancies
- Controversy: Causality versus association remains debated
Neurological and Sensory Mechanisms
| Mechanism | Description | Clinical Manifestation |
|---|---|---|
| Olfactory Hypersensitivity | Heightened smell sensitivity mediated by estrogen effects on olfactory epithelium | Specific odors (cooking smells, perfumes, tobacco) trigger intense nausea; food aversions develop |
| Vestibular Sensitivity | Increased sensitivity of vestibular system during pregnancy | Motion sensitivity; women with history of motion sickness more severely affected |
| Central Sensitization | Repeated emetic stimuli may lower threshold for subsequent episodes | Anticipatory nausea; conditioned responses to previously neutral stimuli |
| Autonomic Dysfunction | Altered autonomic tone during pregnancy | May contribute to vasomotor symptoms accompanying nausea |
Evolutionary and Adaptive Perspective
The “Maternal-Embryo Protection Hypothesis”: This theory proposes that NVP evolved as a protective mechanism:
- Peak symptoms during organogenesis (weeks 6 to 12) when fetus is most vulnerable to teratogens
- Food aversions typically target potentially harmful substances (strong flavors, meat, alcohol, bitter compounds)
- Cultures with lower NVP prevalence tend to have diets lower in potentially toxic compounds
- NVP associated with lower miscarriage rates and better pregnancy outcomes
While this theory is debated, it provides a framework for understanding why NVP is so common and may help reassure patients that their symptoms, while distressing, may serve a protective function.
How Different Conditions Cause NVP Symptoms
| Condition | Mechanism | Treatment Implication |
|---|---|---|
| Physiologic NVP (hCG-mediated) | hCG stimulates CTZ; peaks at 9 to 12 weeks then plateaus | Symptoms self-limited; supportive care often sufficient; expect improvement after first trimester |
| Gastric Dysmotility Component | Progesterone-induced delayed gastric emptying; gastric dysrhythmias | Prokinetic agents (metoclopramide) may be helpful; small frequent meals reduce gastric distension |
| Vestibular Sensitivity | Enhanced vestibular input to vomiting center | Antihistamines (meclizine, dimenhydrinate) particularly effective |
| Serotonin-Mediated | 5-HT3 receptor activation in CTZ and vagal afferents | 5-HT3 antagonists (ondansetron) effective for refractory cases |
| Gestational Transient Thyrotoxicosis | hCG cross-reactivity with TSH receptor causes hyperthyroidism | Usually resolves spontaneously; beta-blockers for symptomatic relief if needed; avoid antithyroid drugs |
| H. pylori-Associated | Gastric inflammation exacerbates hormonal effects | Testing and postpartum eradication may prevent recurrence in future pregnancies |
Often Overlooked Mechanism
Vitamin B6 deficiency: Pyridoxine is a cofactor for numerous enzymatic reactions involved in amino acid metabolism. Deficiency may develop rapidly in pregnancy due to increased requirements and poor intake secondary to nausea. This creates a potential vicious cycle where deficiency worsens nausea, which further impairs intake. This explains why vitamin B6 supplementation is effective as first-line therapy and should be started early in the course of symptoms.
Complications of Prolonged or Severe Vomiting
| Complication | Mechanism | Prevention/Management |
|---|---|---|
| Wernicke Encephalopathy | Thiamine (vitamin B1) deficiency from prolonged poor intake and vomiting; glucose administration can precipitate | ALWAYS give thiamine before or with glucose-containing fluids; symptoms include confusion, ataxia, ophthalmoplegia |
| Hypokalemia | Potassium loss through vomiting; renal wasting due to alkalosis | Monitor electrolytes; replace potassium in IV fluids; can cause cardiac arrhythmias and muscle weakness |
| Metabolic Alkalosis | Loss of gastric hydrochloric acid through vomiting | Usually corrects with volume and electrolyte replacement |
| Mallory-Weiss Tear | Forceful vomiting causes mucosal laceration at gastroesophageal junction | Presents with hematemesis; usually self-limited; endoscopy if bleeding persists |
| Acute Kidney Injury | Pre-renal azotemia from severe dehydration | Aggressive IV fluid resuscitation; monitor renal function |
3. History Taking
A comprehensive approach to eliciting the nausea and vomiting history in pregnancy
Red Flags — Require Urgent Evaluation
- Onset after 9 weeks gestation — Suggests non-pregnancy etiology
- Fever greater than 38°C — Consider infection (pyelonephritis, appendicitis, cholecystitis)
- Severe abdominal pain — May indicate surgical emergency
- Hematemesis or coffee-ground emesis — Mallory-Weiss tear, peptic ulcer disease
- Neurological symptoms — Confusion, ataxia, visual changes suggest Wernicke encephalopathy
- Weight loss greater than 5% of pre-pregnancy weight — Indicates hyperemesis gravidarum
- Unable to tolerate any oral intake for more than 24 hours — Risk of dehydration and ketonuria
- Signs of severe dehydration — Oliguria, dark urine, syncope, tachycardia
- Headache with visual changes — Consider preeclampsia if beyond 20 weeks
- Bilious (green) vomiting — Suggests bowel obstruction
Systematic History: The “HEAVES” Approach
Use the mnemonic “HEAVES” to ensure comprehensive history taking for nausea and vomiting in pregnancy:
- H — How and When: Timing of onset, pattern throughout day, relationship to gestational age, progression of symptoms
- E — Eating and Drinking: Oral intake tolerance, food aversions, triggers, last meal kept down, current hydration status
- A — Associated Symptoms: Abdominal pain, fever, diarrhea, headache, urinary symptoms, neurological complaints
- V — Volume and Character: Frequency of vomiting episodes, nature of vomitus (food, bile, blood), severity using validated scales
- E — Effect on Life: Weight change, ability to work, hydration (urine output, dizziness), mood and coping
- S — Special Factors: Prior pregnancy history, medications tried, risk factors, psychiatric history, social support
Critical First Step: Confirm Pregnancy Details
| Question | Purpose | Clinical Relevance |
|---|---|---|
| “What is your due date?” | Establish gestational age | NVP typically 4 to 16 weeks; onset outside this window raises suspicion for other causes |
| “Have you had an ultrasound?” | Confirm viability and dating | Rules out missed miscarriage, molar pregnancy, multiple gestation |
| “Is this a singleton pregnancy?” | Identify multiple gestation | Twins/triplets have higher hCG and increased NVP severity |
| “Any bleeding or cramping?” | Assess pregnancy viability | Threatened miscarriage, ectopic pregnancy may present with nausea |
Targeted Questions by Suspected Cause
| Suspected Cause | Key Features | Ask This Question |
|---|---|---|
| Physiologic NVP | Onset 4 to 9 weeks, improves by 14 to 16 weeks, worse with empty stomach, no fever/pain | “Did your symptoms start within the first two months of pregnancy and are they improving now?” |
| Hyperemesis Gravidarum | Weight loss, ketonuria, unable to maintain hydration, significantly impaired function | “Have you lost weight since becoming pregnant? How much? Can you keep any fluids down?” |
| Urinary Tract Infection / Pyelonephritis | Dysuria, frequency, flank pain, fever | “Do you have any burning with urination, need to urinate frequently, or back pain?” |
| Gastroesophageal Reflux Disease | Heartburn, regurgitation, worse when lying flat, post-prandial symptoms | “Do you experience burning in your chest or throat? Does lying down make it worse?” |
| Gastroparesis | Early satiety, bloating, post-prandial fullness, prior diabetes or surgery | “Do you feel full very quickly after eating? Do you feel bloated even with small meals?” |
| Cholecystitis / Biliary Colic | Right upper quadrant pain, worse after fatty meals, radiation to shoulder | “Do you have pain under your right ribs, especially after eating fatty or greasy foods?” |
| Appendicitis | Periumbilical pain migrating to right lower quadrant, fever, anorexia | “Did your abdominal pain start around your belly button and move to your right side?” |
| Pancreatitis | Severe epigastric pain radiating to back, worse after eating | “Do you have severe pain in the upper middle of your abdomen that goes through to your back?” |
| Preeclampsia | After 20 weeks, headache, visual changes, right upper quadrant pain, edema | “Have you had any headaches, vision changes, or sudden swelling in your face or hands?” |
| Acute Fatty Liver of Pregnancy | Third trimester, malaise, jaundice, right upper quadrant pain, hypoglycemia | “Have you noticed yellowing of your eyes or skin? Any unusual fatigue or confusion?” |
Quantifying Symptom Severity
The PUQE Score (Pregnancy-Unique Quantification of Emesis)
A validated tool to quantify NVP severity over the past 24 hours. Ask these three questions:
- Nausea duration: “For how many hours have you felt nauseated?” (1 = none, 5 = more than 6 hours)
- Vomiting episodes: “How many times have you vomited?” (1 = none, 5 = 7 or more times)
- Retching episodes: “How many times have you had dry heaves without vomiting?” (1 = none, 5 = 7 or more times)
Interpretation: Score 3 to 6 = mild NVP; Score 7 to 12 = moderate NVP; Score 13 to 15 = severe NVP
Medication and Supplement History
Medications That May Worsen Nausea
- Iron supplements — Common cause; consider switching formulation or timing
- Prenatal vitamins — Iron content and size may worsen symptoms
- Opioid analgesics — Direct emetic effect via CTZ stimulation
- Antibiotics — Especially erythromycin and metronidazole
- Selective serotonin reuptake inhibitors — May cause or worsen nausea
- Theophylline — Gastrointestinal side effects common
Current and Previously Tried Treatments
- Ginger supplements: “Have you tried ginger? What dose?”
- Vitamin B6 (pyridoxine): “Are you taking B6? How much and how often?”
- Doxylamine: “Have you tried Unisom or any antihistamine?”
- Prescription antiemetics: “What medications have been prescribed? Did they help?”
- Acupressure bands: “Have you tried pressure wristbands?”
Obstetric and Gynecologic History
| Question | Significance |
|---|---|
| “Did you experience nausea in previous pregnancies?” | Prior NVP strongly predicts current symptoms; recurrence of hyperemesis gravidarum is 15 to 20% |
| “Were you hospitalized for vomiting in a previous pregnancy?” | History of hyperemesis gravidarum is the strongest predictor of severe disease |
| “Did you have nausea with birth control pills?” | Estrogen sensitivity predicts NVP severity |
| “Any history of molar pregnancy?” | Should prompt early ultrasound if symptoms severe |
Social and Psychological History
Social Factors
- Living situation: Who is available to help with meals and hydration?
- Work status: Can she take time off if needed? Type of work and exposures?
- Other children: Childcare demands may prevent adequate rest
- Financial concerns: Can she afford medications? Time off work?
- Food security: Access to small, frequent meals?
Psychological Assessment
- Depression screening: “How has your mood been?” — Depression common with severe NVP
- Anxiety: “Are you feeling worried or anxious about this pregnancy?”
- Coping: “How are you managing emotionally with these symptoms?”
- Suicidal ideation: Severe hyperemesis gravidarum associated with increased risk — screen if symptoms prolonged
- Desired pregnancy: Unplanned pregnancy may affect symptom perception and coping
Risk Factor Assessment
| Risk Factor | How to Assess | Management Implication |
|---|---|---|
| Motion sickness history | “Do you get carsick or seasick easily?” | Suggests vestibular sensitivity; antihistamines may be particularly effective |
| Migraine history | “Do you have a history of migraines?” | Shared pathophysiology; may predict symptom severity |
| Family history of hyperemesis gravidarum | “Did your mother or sisters have severe vomiting in pregnancy?” | Genetic component; be vigilant for severe disease |
| Helicobacter pylori infection | “Have you ever been treated for stomach ulcers or H. pylori?” | Consider testing if symptoms severe or refractory |
| Thyroid disease | “Do you have any thyroid problems?” | Pre-existing hyperthyroidism may worsen; also check for gestational thyrotoxicosis |
Clinical Pearl: Don’t Forget the Basics
Always ask about last menstrual period and pregnancy testing — occasionally, women present with “NVP” symptoms before knowing they are pregnant, or symptoms may continue after a missed miscarriage. Similarly, always consider ectopic pregnancy in early pregnancy with nausea and abdominal pain, especially if no intrauterine pregnancy has been confirmed on ultrasound.
4. Physical Examination
A systematic approach for evaluating nausea and vomiting in pregnancy
Systematic Framework: The primary goals of physical examination in NVP are to: (1) assess hydration status and severity, (2) identify signs suggesting alternative diagnoses, and (3) evaluate for complications of prolonged vomiting. A focused but thorough examination is essential.
General Inspection
- Appearance: Does the patient look unwell, fatigued, or distressed? Signs of weight loss?
- Nutritional status: Temporal wasting, loose-fitting clothes suggesting recent weight loss
- Hydration clues: Dry lips, sunken eyes, decreased skin turgor
- Mental status: Alertness and orientation — confusion may indicate Wernicke encephalopathy or severe metabolic derangement
- Affect: Signs of depression or psychological distress
- Odor: Ketotic (fruity) breath odor suggests starvation ketosis
Vital Signs
| Vital Sign | What to Look For | Clinical Significance |
|---|---|---|
| Temperature | Fever greater than 38°C (100.4°F) | Suggests infection (pyelonephritis, appendicitis, cholecystitis); NVP itself does not cause fever |
| Heart Rate | Tachycardia greater than 100 bpm; resting heart rate typically increases 10 to 20 bpm in pregnancy | Tachycardia suggests dehydration, hypovolemia, or underlying infection; may also indicate hyperthyroidism |
| Blood Pressure | Hypotension (systolic less than 90 mmHg); orthostatic changes (drop greater than 20 mmHg systolic on standing) | Orthostatic hypotension indicates significant volume depletion requiring IV fluids |
| Respiratory Rate | Tachypnea; Kussmaul breathing (deep, labored) | May indicate metabolic acidosis (rare) or compensation for severe metabolic derangement |
| Weight | Compare to pre-pregnancy weight and recent documented weights | Weight loss greater than 5% of pre-pregnancy weight defines hyperemesis gravidarum; objective measure of severity |
Orthostatic Vital Signs
Always check orthostatic vital signs in patients with significant vomiting. Have the patient lie supine for 2 to 3 minutes, then stand for 1 minute before rechecking. A drop in systolic blood pressure greater than 20 mmHg or increase in heart rate greater than 20 bpm suggests significant hypovolemia requiring intravenous fluid resuscitation.
Head, Eyes, Ears, Nose, and Throat Examination
Eyes
- Scleral icterus: Jaundice suggests liver pathology (cholestasis, acute fatty liver, hepatitis)
- Conjunctival pallor: Anemia from nutritional deficiency or occult bleeding
- Nystagmus: Horizontal nystagmus may indicate Wernicke encephalopathy — urgent finding
- Ophthalmoplegia: Lateral gaze palsy — another sign of Wernicke encephalopathy
- Sunken eyes: Sign of dehydration
Mouth and Throat
- Mucous membranes: Dry, tacky membranes indicate dehydration
- Tongue: Dry, furrowed tongue; glossitis may suggest B-vitamin deficiency
- Dental erosion: Enamel erosion on posterior teeth from repeated acid exposure
- Pharyngeal erythema: Irritation from repeated vomiting
- Parotid enlargement: Bilateral swelling may occur with repeated vomiting
Thyroid Examination
- Size: Mild diffuse enlargement may be normal in pregnancy; significant goiter warrants investigation
- Nodules: Palpable nodules require further evaluation
- Tremor: Fine tremor of outstretched hands suggests hyperthyroidism
- Eye signs: Lid lag, proptosis suggest Graves disease rather than gestational thyrotoxicosis
Cardiovascular Examination
- Jugular venous pressure: Low JVP indicates hypovolemia; elevated JVP suggests cardiac cause
- Heart sounds: Flow murmurs common in pregnancy; new murmurs warrant investigation
- Peripheral pulses: Weak, thready pulses suggest significant dehydration
- Capillary refill: Prolonged (greater than 2 seconds) indicates poor perfusion
- Peripheral edema: Assess for signs of preeclampsia if beyond 20 weeks
Abdominal Examination
| Component | Findings | Clinical Significance |
|---|---|---|
| Inspection | Distension, visible peristalsis, scars from prior surgery | Distension with visible peristalsis suggests bowel obstruction |
| Auscultation | Bowel sounds — hyperactive, hypoactive, or absent | High-pitched, hyperactive bowel sounds suggest obstruction; absent sounds suggest ileus |
| Palpation — Epigastric | Tenderness in upper abdomen | Epigastric tenderness may suggest gastritis, peptic ulcer, or pancreatitis |
| Palpation — Right Upper Quadrant | Murphy’s sign (inspiratory arrest with RUQ palpation) | Positive Murphy’s sign suggests cholecystitis; also consider HELLP syndrome and acute fatty liver of pregnancy |
| Palpation — Right Lower Quadrant | Tenderness, guarding, rebound | Consider appendicitis — note that appendix may be displaced cephalad by gravid uterus |
| Palpation — Suprapubic | Uterine size, tenderness | Uterine size should correlate with dates; uterine tenderness may suggest infection |
| Costovertebral Angle | Tenderness to percussion | CVA tenderness strongly suggests pyelonephritis |
Neurological Examination
Wernicke Encephalopathy — Do Not Miss
The classic triad of confusion, ataxia, and ophthalmoplegia is present in only about 30% of cases. Any neurological abnormality in a patient with prolonged vomiting should raise concern for thiamine deficiency. Key findings include:
- Mental status: Confusion, disorientation, apathy, memory impairment
- Eye findings: Horizontal nystagmus, lateral rectus palsy (cranial nerve VI), conjugate gaze palsies
- Gait: Ataxia, wide-based gait, inability to tandem walk
- Reflexes: May be diminished (peripheral neuropathy) or hyperactive
Action: If suspected, give thiamine 100 mg IV immediately BEFORE any glucose-containing fluids.
Skin Examination
- Turgor: Decreased skin turgor (tenting) indicates dehydration — test on chest or forehead in pregnancy
- Color: Pallor (anemia), jaundice (liver disease), cyanosis (rare, severe cases)
- Petechiae or bruising: May indicate coagulopathy (HELLP, acute fatty liver of pregnancy)
- Rashes: May suggest underlying infection or drug reaction
Expected Findings by Etiology
| Condition | General Appearance | Vital Signs | Key Examination Findings |
|---|---|---|---|
| Physiologic NVP (mild) | Well-appearing | Normal | Normal examination; no dehydration |
| Hyperemesis Gravidarum | Ill-appearing, fatigued, weight loss evident | Tachycardia, orthostatic hypotension | Dry mucous membranes, decreased skin turgor, ketotic breath; otherwise non-focal |
| Pyelonephritis | Ill, febrile | Fever, tachycardia | Costovertebral angle tenderness; may have suprapubic tenderness |
| Appendicitis | Uncomfortable, guarding | Fever (often low-grade), tachycardia | RLQ tenderness (may be higher in late pregnancy), guarding, rebound |
| Cholecystitis | Uncomfortable, worse after eating | May have fever, tachycardia | RUQ tenderness, positive Murphy’s sign |
| Pancreatitis | Severely ill | Tachycardia, may be hypotensive | Epigastric tenderness, guarding; rarely Cullen or Grey Turner signs |
| Gestational Thyrotoxicosis | Anxious, tremulous | Tachycardia (often greater than 100 bpm), widened pulse pressure | Tremor, hyperreflexia, warm moist skin; NO eye signs (differentiates from Graves) |
| Wernicke Encephalopathy | Confused, disoriented | Variable | Nystagmus, ophthalmoplegia, ataxia, confusion |
| Preeclampsia with Nausea | May appear well or ill | Hypertension (BP greater than 140/90) | Edema (especially facial/hand), RUQ tenderness (HELLP), hyperreflexia, clonus |
Important Teaching Point
Normal examination is expected in physiologic NVP. The majority of patients with nausea and vomiting in pregnancy will have completely normal physical examinations aside from signs of mild dehydration. The purpose of the examination is not to “find something wrong” but rather to identify those patients who have findings suggesting an alternative diagnosis or complications of severe disease. A normal examination in a patient with typical history is reassuring and supports the diagnosis of physiologic NVP.
Clinical Assessment of Dehydration Severity
| Parameter | Mild Dehydration | Moderate Dehydration | Severe Dehydration |
|---|---|---|---|
| Mental Status | Alert | Fatigued, irritable | Lethargic, confused |
| Heart Rate | Normal to slightly elevated | Tachycardic | Markedly tachycardic |
| Blood Pressure | Normal | Orthostatic changes | Hypotensive |
| Mucous Membranes | Slightly dry | Dry | Parched, cracked |
| Skin Turgor | Normal | Slightly decreased | Markedly decreased (tenting) |
| Urine Output | Decreased, concentrated | Oliguria | Anuria |
| Capillary Refill | Normal (less than 2 seconds) | 2 to 4 seconds | Greater than 4 seconds |
| Management | Oral rehydration trial | IV fluids often needed | Urgent IV resuscitation |
5. Differential Diagnosis
Systematic approach organized by probability, timing, and clinical features
While the vast majority of nausea and vomiting in early pregnancy represents physiologic NVP, it is essential to consider alternative diagnoses, particularly when the presentation is atypical. The key to differential diagnosis is recognizing features that should prompt investigation beyond “routine” NVP: late onset, fever, localized pain, abnormal examination findings, or failure to improve with standard therapy.
First Trimester Nausea and Vomiting (Less Than 14 Weeks)
| Probability | Condition | Key Features | Red Flags |
|---|---|---|---|
| COMMON (greater than 90%) | Physiologic Nausea and Vomiting of Pregnancy | Onset 4 to 9 weeks; improves by 14 to 16 weeks; worse with empty stomach; no fever or pain; normal examination | None — this is the expected presentation |
| COMMON (0.3 to 3%) | Hyperemesis Gravidarum | Severe, persistent vomiting; weight loss greater than 5%; ketonuria; unable to maintain hydration; may require hospitalization | Neurological symptoms (Wernicke), severe electrolyte abnormalities |
| LESS COMMON (5 to 10%) | Urinary Tract Infection | Dysuria, frequency, urgency; suprapubic discomfort; may be asymptomatic in pregnancy | Fever, flank pain (pyelonephritis) |
| LESS COMMON | Gastroesophageal Reflux Disease | Heartburn, regurgitation; worse lying flat; may coexist with NVP | Dysphagia, odynophagia, hematemesis |
| LESS COMMON | Gestational Transient Thyrotoxicosis | Occurs in up to 60% of hyperemesis gravidarum; palpitations, tremor, anxiety; suppressed TSH with elevated free T4 | Eye signs suggest Graves disease instead |
| UNCOMMON BUT SERIOUS | Molar Pregnancy (Gestational Trophoblastic Disease) | Markedly elevated hCG; uterus large for dates; vaginal bleeding; “snowstorm” appearance on ultrasound | Very high hCG, theca lutein cysts, early preeclampsia |
| UNCOMMON BUT SERIOUS | Ectopic Pregnancy | Nausea with abdominal/pelvic pain; vaginal bleeding; positive pregnancy test without IUP on ultrasound | Hemodynamic instability, acute abdomen |
| UNCOMMON BUT SERIOUS | Appendicitis | Periumbilical pain migrating to RLQ; anorexia; low-grade fever; incidence 1 in 1,500 pregnancies | Peritonitis, perforation |
Second and Third Trimester Nausea and Vomiting (Greater Than 14 Weeks)
Key Principle: New-onset nausea and vomiting after the first trimester is atypical for physiologic NVP and should prompt investigation for alternative causes. While some women have persistent NVP throughout pregnancy, new symptoms arising after 14 to 16 weeks warrant a broader differential.
| Probability | Condition | Typical Timing | Key Distinguishing Features |
|---|---|---|---|
| COMMON | Persistent Nausea and Vomiting of Pregnancy | Continuation from first trimester | Symptoms continuous since early pregnancy; gradual improvement; no new features |
| COMMON | Gastroesophageal Reflux Disease | Worsens as pregnancy progresses | Heartburn predominates; worse lying flat and after meals; responds to antacids/PPIs |
| LESS COMMON | Cholelithiasis and Cholecystitis | Any trimester; more common later | RUQ pain worse after fatty meals; fever if cholecystitis; Murphy’s sign positive |
| LESS COMMON | Pyelonephritis | Any trimester | Fever, flank pain, CVA tenderness; may have preceding UTI symptoms |
| LESS COMMON | Pancreatitis | Any trimester; often related to gallstones | Severe epigastric pain radiating to back; elevated lipase; may be severe |
| UNCOMMON BUT SERIOUS | Preeclampsia with Severe Features | After 20 weeks (usually third trimester) | Hypertension, proteinuria, RUQ pain, headache, visual changes, elevated LFTs |
| UNCOMMON BUT SERIOUS | HELLP Syndrome | Third trimester or postpartum | Hemolysis, Elevated Liver enzymes, Low Platelets; RUQ pain; may lack hypertension |
| UNCOMMON BUT SERIOUS | Acute Fatty Liver of Pregnancy | Third trimester (usually 34 to 36 weeks) | Malaise, nausea, RUQ pain, jaundice; hypoglycemia; coagulopathy; high mortality if missed |
| UNCOMMON BUT SERIOUS | Intrahepatic Cholestasis of Pregnancy | Third trimester | Pruritus (especially palms/soles) predominates; mild jaundice; elevated bile acids |
Anatomical Approach to Non-Obstetric Causes
Gastrointestinal
Gastroesophageal reflux disease
Gastroparesis
Peptic ulcer disease
Gastroenteritis
Small bowel obstruction
Inflammatory bowel disease flare
Hepatobiliary and Pancreatic
Cholecystitis / biliary colic
Pancreatitis
Hepatitis (viral, drug-induced)
Acute fatty liver of pregnancy
HELLP syndrome
Intrahepatic cholestasis of pregnancy
Genitourinary
Urinary tract infection
Pyelonephritis
Nephrolithiasis
Ovarian torsion
Degenerating fibroid
Other Systems
Thyroid disorders (hyper/hypothyroidism)
Diabetic ketoacidosis
Adrenal insufficiency
Migraine
Increased intracranial pressure
Vestibular disorders
Pregnancy-Specific Conditions Causing Nausea and Vomiting
| Condition | Typical Timing | Key Features | Diagnostic Clues |
|---|---|---|---|
| Physiologic NVP | 4 to 16 weeks | Most common; improves with time; no systemic features | Clinical diagnosis; rule out alternatives |
| Hyperemesis Gravidarum | First trimester (may persist) | Severe end of NVP spectrum; greater than 5% weight loss; ketonuria | Ketones in urine; electrolyte abnormalities |
| Molar Pregnancy | First trimester | Markedly elevated hCG; vaginal bleeding; uterus large for dates | Ultrasound “snowstorm”; very high hCG |
| Multiple Gestation | First trimester | Higher hCG levels; more severe NVP; uterus large for dates | Ultrasound confirms twins/triplets |
| Preeclampsia | After 20 weeks | Hypertension, proteinuria, headache, visual changes, RUQ pain | BP greater than 140/90; urine protein; abnormal labs |
| HELLP Syndrome | Third trimester/postpartum | RUQ/epigastric pain, nausea; may lack hypertension | Hemolysis, LFTs elevated, platelets low |
| Acute Fatty Liver of Pregnancy | Third trimester | Malaise, nausea, jaundice, encephalopathy | Hypoglycemia, coagulopathy, elevated ammonia |
Drug-Induced Nausea and Vomiting in Pregnancy
| Drug or Drug Class | Mechanism | Characteristics | Management |
|---|---|---|---|
| Iron Supplements | Direct GI irritation; constipation worsens nausea | Very common; dose-related; often worsens pre-existing NVP | Take with food; reduce dose; switch formulation; consider IV iron if severe anemia |
| Prenatal Vitamins | Iron content; large pill size triggers gag reflex | Worse on empty stomach; may have metallic taste | Take at night; try gummy vitamins; separate iron from other vitamins |
| Opioid Analgesics | Direct CTZ stimulation; delayed gastric emptying | Common; dose-related; tolerance may develop | Use lowest effective dose; co-prescribe antiemetic if needed |
| Antibiotics | GI irritation; alteration of gut flora; direct emetic effect | Varies by antibiotic; erythromycin and metronidazole worst | Take with food; consider alternative antibiotic if possible |
| Selective Serotonin Reuptake Inhibitors | Serotonergic effects on GI tract and CTZ | Usually improves after 1 to 2 weeks; may worsen at initiation | Start low and titrate slowly; take with food; usually improves with time |
| Aspirin and NSAIDs | Gastric irritation; prostaglandin inhibition | Note: NSAIDs generally avoided in pregnancy, especially third trimester | Avoid if possible; use acetaminophen instead |
| Metformin | GI side effects common; mechanism not fully understood | Dose-related; may improve with extended-release formulation | Start low, increase gradually; take with meals; consider XR formulation |
Quick Reference: “If You See This, Think This”
| Clinical Clue | Think This First | Next Step |
|---|---|---|
| Onset before 9 weeks, improves by 14 weeks, no red flags | Physiologic NVP | Reassurance, dietary modification, consider vitamin B6 |
| Weight loss greater than 5%, ketonuria, unable to keep fluids down | Hyperemesis Gravidarum | IV fluids, thiamine, antiemetics, check electrolytes |
| Onset after 9 weeks with no prior symptoms | Non-pregnancy cause | Broad evaluation: labs, imaging as indicated |
| Fever with flank pain and CVA tenderness | Pyelonephritis | Urinalysis, urine culture, IV antibiotics |
| RUQ pain worse after fatty meals | Biliary colic or cholecystitis | RUQ ultrasound, LFTs, lipase |
| Severe epigastric pain radiating to back | Pancreatitis | Lipase, RUQ ultrasound, supportive care |
| Markedly elevated hCG with vaginal bleeding | Molar pregnancy | Pelvic ultrasound, refer to gynecologic oncology |
| Tachycardia, tremor, suppressed TSH | Gestational thyrotoxicosis | Thyroid function tests; usually self-limited |
| Confusion, nystagmus, ataxia in prolonged vomiting | Wernicke encephalopathy | IV thiamine IMMEDIATELY (before glucose) |
| After 20 weeks: hypertension, headache, RUQ pain | Preeclampsia / HELLP | BP, urine protein, CBC, LFTs, consider delivery |
| Third trimester: jaundice, hypoglycemia, coagulopathy | Acute Fatty Liver of Pregnancy | Urgent delivery; supportive care; high mortality if delayed |
| Periumbilical pain migrating to RLQ with fever | Appendicitis | Surgical consultation; imaging (MRI preferred in pregnancy) |
Clinical Pearl: The “Two-Week Rule”
If nausea and vomiting persist despite appropriate antiemetic therapy for two weeks, or if symptoms are worsening rather than improving, reconsider the diagnosis. This is the time to step back, repeat the history looking for missed clues, and expand the investigation. Persistent or refractory symptoms may indicate an underlying condition that was initially attributed to NVP.
6. Diagnostic Investigations
A stepwise, clinically-guided approach to investigation
Investigation of nausea and vomiting in pregnancy should be guided by clinical presentation. Mild, typical NVP with onset in the expected window and no red flags requires minimal or no investigation. More severe presentations, atypical features, or failure to respond to treatment warrant a systematic workup. The goal is to confirm the severity of NVP, identify complications, and exclude alternative diagnoses.
When to Investigate
Investigation Usually NOT Required
- Typical onset (4 to 9 weeks gestation)
- Mild symptoms with maintained oral intake
- No weight loss or minimal weight loss
- No red flag symptoms
- Normal physical examination
- Symptoms improving as expected
Investigation Required
- Moderate-to-severe symptoms (PUQE score greater than 6)
- Weight loss greater than 5%
- Signs of dehydration
- Unable to tolerate oral intake
- Atypical timing (onset after 9 weeks)
- Any red flag symptoms
- Failure to respond to initial therapy
- Hospitalization required
Baseline Investigations for Moderate-to-Severe NVP
| Investigation | Purpose | What to Look For | Practical Points |
|---|---|---|---|
| Urinalysis (dipstick and microscopy) | Assess hydration; screen for UTI | Ketones (starvation), specific gravity (concentration), leukocytes/nitrites (UTI) | Ketonuria indicates need for IV fluids; trace ketones common even in mild NVP |
| Urine Culture | Exclude UTI/asymptomatic bacteriuria | Pathogen identification; greater than 100,000 CFU/mL significant | UTI common in pregnancy and may present with nausea alone |
| Basic Metabolic Panel | Assess electrolytes and renal function | Hypokalemia, hypochloremia, hyponatremia; elevated creatinine (dehydration) | Hypokalemia most common abnormality; may cause muscle weakness and arrhythmias |
| Complete Blood Count | Baseline; assess for infection or anemia | Hemoconcentration (dehydration), leukocytosis (infection), anemia | Elevated hematocrit may indicate severe dehydration |
| Liver Function Tests | Screen for hepatobiliary disease | Elevated transaminases (hepatitis, HELLP, AFLP); elevated bilirubin (cholestasis) | Mild transaminase elevation may occur in severe HG; marked elevation suggests other pathology |
| Thyroid Function Tests (TSH, free T4) | Screen for thyroid dysfunction | Suppressed TSH with elevated free T4 (gestational thyrotoxicosis) | Up to 60% of HG patients have biochemical hyperthyroidism; usually transient |
Imaging Studies
| Imaging Study | Indications | What It Shows | Safety in Pregnancy |
|---|---|---|---|
| Pelvic Ultrasound | All patients if not recently performed; essential for severe or atypical presentations | Confirms IUP, gestational age, viability; excludes molar pregnancy, multiple gestation, ectopic | Safe; no ionizing radiation; first-line imaging in pregnancy |
| Right Upper Quadrant Ultrasound | RUQ pain; suspected biliary disease | Gallstones, cholecystitis (wall thickening, pericholecystic fluid), biliary dilation | Safe; no radiation; first-line for biliary evaluation |
| Renal Ultrasound | Flank pain; suspected nephrolithiasis or hydronephrosis | Hydronephrosis (common in pregnancy), renal stones, pyelonephritis changes | Safe; note that mild hydronephrosis is physiologic in pregnancy |
| Abdominal MRI | Suspected appendicitis or other surgical condition when ultrasound non-diagnostic | Appendicitis, bowel obstruction, other intra-abdominal pathology | Preferred over CT; avoid gadolinium if possible (especially first trimester) |
| Abdominal CT | Emergency situations when MRI unavailable and diagnosis critical | Appendicitis, bowel obstruction, other acute pathology | Use only when benefits clearly outweigh risks; shield pelvis when possible |
Imaging Safety in Pregnancy
Hierarchy of safety: Ultrasound (safest) → MRI without gadolinium → CT with shielding → CT without shielding. The radiation dose from a single CT scan is well below the threshold for fetal harm, and necessary imaging should never be withheld in a pregnant patient with a potentially serious condition. The greater risk is delayed diagnosis of conditions like appendicitis.
Targeted Investigations by Clinical Suspicion
If Suspecting Hyperemesis Gravidarum with Complications
Standard Workup
- Electrolytes: Hypokalemia (less than 3.5 mEq/L), hyponatremia, hypochloremic metabolic alkalosis
- Renal function: Elevated BUN/creatinine ratio (pre-renal azotemia)
- Urinalysis: Ketonuria (1+ to 4+), elevated specific gravity
- TSH and free T4: Suppressed TSH (often less than 0.1) with elevated free T4
If Severe or Prolonged
- Magnesium and phosphate: Often depleted with prolonged vomiting
- Vitamin levels: Thiamine (B1), if Wernicke suspected (often treat empirically)
- Liver function: Mild elevations common; marked elevation suggests other pathology
- Amylase/lipase: If epigastric pain present
If Suspecting Infectious Etiology
Urinary Tract Infection / Pyelonephritis
- Urinalysis: Pyuria (greater than 10 WBC/hpf), bacteriuria, positive nitrites/leukocyte esterase
- Urine culture: Gold standard; obtain before antibiotics
- Blood cultures: If pyelonephritis suspected or patient septic
- Renal ultrasound: If complicated UTI or poor response to treatment
Gastroenteritis
- Stool studies: If diarrhea predominates; culture, ova and parasites, C. difficile
- Electrolytes: May have hypokalemia from diarrhea
- Usually clinical diagnosis: Self-limited; investigate if prolonged
If Suspecting Hepatobiliary or Pancreatic Disease
Cholecystitis / Biliary Colic
- Liver function tests: May show elevated ALP, GGT, and transaminases
- Bilirubin: Elevated if obstruction present
- RUQ ultrasound: Gallstones, wall thickening, pericholecystic fluid, sonographic Murphy’s sign
- MRCP: If common bile duct stone suspected
Pancreatitis
- Lipase: Greater than 3 times upper limit of normal is diagnostic; more specific than amylase
- Amylase: Less specific; elevated in many conditions
- Liver function tests: May suggest biliary etiology
- Triglycerides: Hypertriglyceridemia is a cause of pancreatitis in pregnancy
- RUQ ultrasound: Look for gallstones as cause
If Suspecting Pregnancy-Specific Liver Disease (After 20 Weeks)
| Condition | Key Laboratory Findings | Distinguishing Features |
|---|---|---|
| Preeclampsia with Severe Features | Elevated AST/ALT (usually less than 500); proteinuria; elevated creatinine; thrombocytopenia possible | Hypertension (BP greater than 140/90); headache; visual changes |
| HELLP Syndrome | Hemolysis (elevated LDH greater than 600, low haptoglobin, schistocytes), AST/ALT elevated, platelets less than 100,000 | May occur without hypertension; RUQ pain common |
| Acute Fatty Liver of Pregnancy | Elevated transaminases (usually less than 500); hypoglycemia; coagulopathy (elevated PT/INR); elevated ammonia; low fibrinogen | Hypoglycemia is key differentiator; encephalopathy if severe |
| Intrahepatic Cholestasis of Pregnancy | Elevated bile acids (greater than 10 micromol/L); mild elevation of transaminases; bilirubin may be mildly elevated | Pruritus predominates (especially palms/soles); nausea less prominent |
Empiric Treatment Trials as Diagnostic Tools
Response to Therapy Can Confirm Diagnosis
In typical presentations of NVP, response to empiric treatment supports the diagnosis. Lack of response should prompt reconsideration of the diagnosis and additional investigation.
- Trial 1 — Vitamin B6 (pyridoxine) ± doxylamine: First-line treatment; improvement within 2 to 3 days supports NVP diagnosis
- Trial 2 — Antiemetic escalation: If no response to B6/doxylamine, add ondansetron or metoclopramide; response supports NVP
- Trial 3 — Acid suppression: If reflux symptoms present, trial of H2 blocker or PPI; response suggests GERD component
- Trial 4 — IV hydration and electrolyte replacement: Improvement with IV fluids supports dehydration as contributor; if no improvement, investigate further
Investigation Algorithm Summary
Stepwise Approach:
- All patients: Confirm gestational age and viable intrauterine pregnancy (ultrasound if not recently done)
- Mild NVP with typical features: No laboratory investigation required; clinical diagnosis
- Moderate-to-severe NVP: Basic metabolic panel, urinalysis, CBC, LFTs, TSH
- Atypical features or red flags: Add targeted investigations based on clinical suspicion
- No improvement with standard therapy: Broaden investigation; consider alternative diagnoses
- Any trimester with fever, localized pain, or systemic illness: Urgent evaluation for surgical and infectious causes
- After 20 weeks with hypertension or RUQ pain: Evaluate for preeclampsia, HELLP, AFLP
Clinical Pearl: The “Recheck TSH” Trap
Gestational transient thyrotoxicosis (GTT) is common in hyperemesis gravidarum and does NOT require antithyroid treatment. It typically resolves by 14 to 18 weeks as hCG levels decline. The key differentiator from Graves disease is the absence of TSH receptor antibodies and absence of eye signs. Unnecessary treatment with antithyroid drugs carries fetal risks. If TSH is suppressed with elevated free T4, recheck in 4 to 6 weeks rather than initiating treatment unless there are clear features of Graves disease.
7. Pattern Recognition and Clinical Decision-Making
Practical algorithms and decision pathways for nausea and vomiting in pregnancy
Step 1: Is This Urgent?
| Clinical Scenario | Urgency Level | Immediate Action |
|---|---|---|
| Confusion, ataxia, or eye movement abnormalities | EMERGENT | IV thiamine 100 mg BEFORE any glucose; admit for Wernicke encephalopathy workup |
| Hemodynamic instability (hypotension, severe tachycardia) | EMERGENT | IV access, aggressive fluid resuscitation, continuous monitoring, identify cause |
| Severe abdominal pain with peritoneal signs | EMERGENT | Surgical consultation; imaging as indicated; NPO status |
| After 20 weeks: hypertension with headache, visual changes, or RUQ pain | EMERGENT | Evaluate for preeclampsia/HELLP; magnesium sulfate if indicated; consider delivery |
| Third trimester: jaundice with coagulopathy | EMERGENT | Evaluate for acute fatty liver of pregnancy; urgent delivery may be required |
| Fever greater than 38°C with flank pain | URGENT | Urinalysis, urine culture, blood cultures; IV antibiotics for pyelonephritis |
| Unable to tolerate any oral intake for greater than 24 hours | URGENT | IV fluids with thiamine; check electrolytes and ketones; antiemetics |
| Weight loss greater than 5% with ketonuria | URGENT | IV hydration; electrolyte replacement; thiamine supplementation; consider admission |
| Hematemesis or coffee-ground emesis | URGENT | NPO; IV access; CBC, type and screen; GI consultation if significant bleeding |
| Mild-to-moderate NVP with typical features, maintaining hydration | ROUTINE | Outpatient management; dietary counseling; first-line antiemetics; follow-up in 1 to 2 weeks |
Step 2: Classify by Severity
Mild NVP
PUQE Score 3 to 6
Maintaining oral intake
No weight loss
No ketonuria
→ Outpatient Management
Moderate NVP
PUQE Score 7 to 12
Reduced oral intake
Weight loss less than 5%
Mild ketonuria (trace to 1+)
→ Trial Outpatient; Consider Day Unit
Severe NVP / Hyperemesis Gravidarum
PUQE Score 13 to 15
Unable to tolerate oral intake
Weight loss greater than 5%
Significant ketonuria (2+ or greater)
→ IV Fluids; Consider Admission
Step 3: Follow the Appropriate Management Pathway
Algorithm A: Mild NVP — Outpatient Management
| Step | Intervention | Details |
|---|---|---|
| 1. Dietary and Lifestyle | Non-pharmacologic measures | Small frequent meals; avoid triggers; bland diet; eat before rising; stay hydrated; ginger products |
| 2. First-Line Pharmacotherapy | Vitamin B6 (pyridoxine) | 10 to 25 mg orally three to four times daily (maximum 200 mg/day) |
| 3. Add if Needed | Doxylamine | 12.5 to 25 mg orally at bedtime (or with each B6 dose); available as Unisom SleepTabs |
| 4. Combination Product | Doxylamine-pyridoxine (Diclegis/Diclectin) | Start with 2 tablets at bedtime; can increase to 4 tablets daily (1 morning, 1 afternoon, 2 bedtime) |
| 5. Follow-up | Reassess in 1 to 2 weeks | If improving, continue; if no improvement, escalate therapy |
Algorithm B: Moderate NVP — Escalation Pathway
| Step | Intervention | Details |
|---|---|---|
| 1. Continue First-Line | Maximize B6/doxylamine | Ensure adequate dosing before escalating |
| 2. Add Second-Line Agent | Choose one: |
|
| 3. If Still Symptomatic | Add metoclopramide | 5 to 10 mg orally or IV every 8 hours (maximum 2 weeks due to tardive dyskinesia risk) |
| 4. Consider Day Unit | IV fluid therapy | IV normal saline or lactated Ringer’s with thiamine; reassess hydration status |
| 5. Reassess | If no improvement | Consider ondansetron; investigate for alternative diagnoses |
Algorithm C: Severe NVP / Hyperemesis Gravidarum — Inpatient Management
| Priority | Intervention | Details |
|---|---|---|
| FIRST | Thiamine replacement | 100 mg IV thiamine BEFORE or WITH glucose-containing fluids (prevents Wernicke) |
| SECOND | IV fluid resuscitation | Normal saline or lactated Ringer’s; avoid dextrose until thiamine given; target urine output greater than 30 mL/hour |
| THIRD | Electrolyte replacement | Replace potassium (target greater than 3.5 mEq/L); correct magnesium and phosphate if low |
| FOURTH | Antiemetic therapy | IV ondansetron 4 to 8 mg every 8 hours; add metoclopramide 10 mg IV every 8 hours if needed |
| FIFTH | NPO then gradual diet advancement | NPO initially; advance to clear liquids, then bland diet as tolerated |
| SIXTH | Consider additional therapies | Corticosteroids (methylprednisolone) for refractory cases after 10 weeks; consider enteral or parenteral nutrition if prolonged |
Critical Reminder: Thiamine First
ALWAYS give thiamine before glucose-containing IV fluids. Glucose metabolism requires thiamine as a cofactor. In a thiamine-depleted patient, giving glucose can precipitate acute Wernicke encephalopathy. This is a preventable cause of permanent neurological damage. When in doubt, give thiamine 100 mg IV first.
“What Do I Do If…” Decision Reference
| Clinical Situation | Immediate Action | Next Step |
|---|---|---|
| Patient cannot keep down oral medications | Switch to IV or rectal antiemetics; consider IV fluids | Ondansetron 4 mg IV; promethazine 25 mg rectally; or metoclopramide 10 mg IV |
| Patient is taking iron supplements | Stop iron temporarily | Iron often worsens NVP; can resume in second trimester or use IV iron if anemic |
| Patient has suppressed TSH with elevated free T4 | Do NOT start antithyroid drugs | Likely gestational transient thyrotoxicosis; recheck in 4 to 6 weeks; treat NVP supportively |
| Patient has ketonuria but is hemodynamically stable | IV fluid bolus; thiamine; antiemetics | Day unit treatment may be sufficient; reassess in 4 to 6 hours; admit if not improving |
| Patient requests termination due to severity of symptoms | Acknowledge suffering; maximize treatment; provide support | Refer for counseling; discuss all options; many improve with aggressive treatment |
| Patient is not improving despite standard therapy for 2 weeks | Reconsider diagnosis; expand investigation | Check for alternative causes; consider gastroenterology referral; trial of corticosteroids |
| Patient has concurrent GERD symptoms | Add acid suppression | H2 blocker (ranitidine, famotidine) or PPI (omeprazole) safe in pregnancy |
| Patient is concerned about medication safety | Provide reassurance with evidence | B6, doxylamine, ondansetron have extensive safety data; untreated severe NVP also carries risks |
| Patient develops signs of Wernicke encephalopathy | Thiamine 100 mg IV immediately; high-dose thiamine protocol | Neurology consultation; MRI brain; continue thiamine 100 mg IV three times daily |
| Patient requires prolonged NPO status | Continue IV thiamine daily; consider nutrition consult | Enteral nutrition (NG/NJ tube) preferred over TPN; involve dietitian |
Troubleshooting Refractory Nausea and Vomiting
Ask These Questions When Standard Therapy Fails
- Is the diagnosis correct? Consider alternative causes (see Task 5)
- Was treatment duration adequate? Some therapies take several days to show effect
- Was dosing optimized? Ensure maximum doses of first-line agents before escalating
- Is the patient taking medications correctly? If vomiting, oral medications may not be absorbed
- Are there exacerbating factors? Iron supplements, prenatal vitamins, stress, triggers
- Is there a psychological component? Anxiety and depression can worsen symptoms and vice versa
- Are multiple mechanisms involved? May need combination therapy targeting different pathways
- Is there an underlying H. pylori infection? Consider testing and postpartum treatment
When to Involve Specialists
| Specialist | Indication |
|---|---|
| Maternal-Fetal Medicine | Hyperemesis gravidarum requiring prolonged hospitalization; refractory cases; considering corticosteroids |
| Gastroenterology | Suspected GI pathology (peptic ulcer, gastroparesis, pancreatitis); refractory symptoms; need for endoscopy |
| General Surgery | Suspected appendicitis, cholecystitis, or bowel obstruction |
| Endocrinology | Unclear whether thyrotoxicosis is gestational versus Graves disease; adrenal insufficiency suspected |
| Neurology | Suspected Wernicke encephalopathy; atypical neurological symptoms |
| Psychiatry | Significant depression or anxiety; suicidal ideation; request for termination due to NVP |
| Nutrition/Dietitian | Prolonged poor intake; need for enteral or parenteral nutrition; significant weight loss |
8. Clinical Pearls and Pitfalls
Practical wisdom — learn from successes and avoid common mistakes
Must-Know Clinical Pearls
Critical Pitfalls to Avoid
Key Takeaways
- Nausea and vomiting of pregnancy affects 50 to 80% of pregnant women, with hyperemesis gravidarum (the severe form) affecting 0.3 to 3%.
- Typical NVP begins at 4 to 6 weeks, peaks at 9 to 12 weeks, and resolves by 14 to 16 weeks; atypical timing should prompt investigation for alternative causes.
- The pathophysiology is multifactorial, involving hCG, estrogen, progesterone, GDF15, and multiple neurotransmitter systems.
- Red flags include late onset, fever, severe abdominal pain, neurological symptoms, weight loss greater than 5%, and inability to maintain hydration.
- Use the “HEAVES” mnemonic for systematic history: How/When, Eating/Drinking, Associated symptoms, Volume/Character, Effect on life, Special factors.
- Physical examination focuses on assessing hydration status, identifying signs of alternative diagnoses, and screening for complications including Wernicke encephalopathy.
- Investigation is guided by severity and clinical features; mild typical NVP requires no workup, while moderate-to-severe or atypical presentations warrant laboratory evaluation.
- First-line treatment is vitamin B6 (pyridoxine) with or without doxylamine; escalate to additional antiemetics as needed.
- Always give thiamine before or with glucose-containing IV fluids to prevent Wernicke encephalopathy.
- Gestational transient thyrotoxicosis does not require antithyroid medication and resolves spontaneously.
- After 20 weeks gestation, new nausea with hypertension or right upper quadrant pain should prompt evaluation for preeclampsia, HELLP syndrome, or acute fatty liver of pregnancy.
- Early, aggressive, and empathetic treatment improves outcomes and quality of life.
Quick Reference Algorithm
Systematic Approach to Nausea and Vomiting in Pregnancy:
- Confirm pregnancy and gestational age — ultrasound if not recently performed
- Assess severity — use PUQE score; check weight change, hydration status, ketonuria
- Screen for red flags — atypical timing, fever, severe pain, neurological symptoms, late pregnancy
- Classify as mild, moderate, or severe — determines management pathway
- Initiate appropriate treatment — lifestyle measures and vitamin B6 for mild; escalate for moderate/severe
- Give thiamine with any IV fluids — before glucose in moderate-to-severe cases
- Investigate if atypical or refractory — consider alternative diagnoses
- Follow up closely — reassess in 1 to 2 weeks; adjust treatment as needed
- Address psychological impact — screen for depression; provide support
- Involve specialists when needed — MFM, GI, surgery, psychiatry as indicated